Reference
Sun C, et al. Successful treatment of Afatinib plus Apatinib using for a lung adenocarcinoma patient with HER-2 V659D mutation: A rare case report. Anti-Cancer Drugs 32: 469-473, No. 4, Apr 2021. Available from: URL: http://doi.org/10.1097/CAD.0000000000000995
Rights and permissions
About this article
Cite this article
Afatinib/rivoceranib. Reactions Weekly 1918, 28 (2022). https://doi.org/10.1007/s40278-022-20485-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-20485-6